AT

Alveo Technologies

www.alveotechnologies.com link_icon

Alveo Technologies Company Research Report



Company Overview


  • Name: Alveo Technologies

  • Mission: "To use our open, accessible, and actionable molecular detection platform to detect pathogens before they spread."

  • Founded: No information is available

  • Founder(s): No information is available

  • Key People:

  • Shaun Holt, Chief Executive Officer

  • Erik Tyrrell-Knott, JD, Chief Business and Strategy Officer

  • Slava Elagin, PhD, MBA, Chief Technology Officer

  • Angie Aquino-Sales, Senior Director, People & Culture

  • Helen Belcastro, VP, Portfolio Planning and Program Management

  • Lisa Charter, VP, Regulatory Affairs, Quality, and Clinical

  • John Daker, VP, Operations

  • Mary K. McFillin, VP, Product Management

  • Headquarters: 1000 Atlantic Avenue, Suite 114, Alameda, CA 94501, USA

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Known For: Alveo Technologies is known for its molecular detection platform that brings molecular testing out of the lab and into the field.


Products


Alveo Platform


  • Description: A portable molecular detection platform designed for rapid, actionable pathogen detection in diverse fields.

  • Key Features:

  • Handheld & Portable

  • Accurate, Rapid Results

  • Multiplex Capable

  • Simple & Easy to Use

  • Affordable & Accessible

  • Cloud-Connected & Secure


be.well™


  • Description: A healthcare solution for rapid, accurate pathogen detection in clinics, medical offices, and pharmacies.

  • Key Features:

  • Handheld Analyzer

  • Designed for point-of-care use

  • Rapid, Accurate Results

  • Companion Mobile App


Alveo Sense Solution


  • Description: Facilitates partnerships to create access to rapid, early detection across various sectors and pathogen types.

  • Key Features:

  • Supports testing across viral, bacterial, or fungal pathogen types

  • Patented Molecular Test

  • Portable with direct electrical impedance sensing


Recent Developments


Press Releases


  • Avian Flu Partnerships:

  • Alveo Technologies developed a groundbreaking product in partnership with x-Ovo, Royal.

  • Product Development & Validation:

  • External validation of the be.well™ COVID-19 test was conducted by Alifax.

  • Device Durability:

  • Mechanical resilience testing revealed that neither a one-meter drop nor constant motion and vibration prevent the device from working.


Partnerships


  • Corteva Agriscience: Collaboration to design crop-specific assays for pathogen detection in agriculture.

  • Fraunhofer: Partnering for veterinary research.

  • x-OvO, Royal GD, and Pharmsure International Ltd.: Developing Avian Influenza molecular test for poultry.


Awards & Certifications


  • ISO Certified: For the design, development, and manufacture of in vitro diagnostic kits and analyzers.

  • CE Mark: For use in the in vitro diagnostic (IVD) molecular testing market.

  • Winner: XPRIZE Grand Prize for Rapid Covid testing.


If you're interested in learning more about our innovative solutions and partnerships, contact us at:
  • Email: partners@alveotechnologies.com

  • Customer Service: support@alveotechnologies.com

  • Phone: +1 833 BE WELL (0) / +1 833 239 3550